Sinoma Science & Technology Co.,Ltd.

SZSE:002080 Stock Report

Market Cap: CN¥21.0b

Sinoma Science & TechnologyLtd Future Growth

Future criteria checks 3/6

Sinoma Science & TechnologyLtd is forecast to grow earnings and revenue by 25.8% and 13.4% per annum respectively. EPS is expected to grow by 25.7% per annum. Return on equity is forecast to be 7.9% in 3 years.

Key information

25.8%

Earnings growth rate

25.7%

EPS growth rate

Chemicals earnings growth38.1%
Revenue growth rate13.4%
Future return on equity7.9%
Analyst coverage

Good

Last updated30 Dec 2024

Recent future growth updates

Recent updates

Some Investors May Be Worried About Sinoma Science & TechnologyLtd's (SZSE:002080) Returns On Capital

Jan 02
Some Investors May Be Worried About Sinoma Science & TechnologyLtd's (SZSE:002080) Returns On Capital

Is Sinoma Science & TechnologyLtd (SZSE:002080) Using Too Much Debt?

Dec 18
Is Sinoma Science & TechnologyLtd (SZSE:002080) Using Too Much Debt?

Sinoma Science & TechnologyLtd's (SZSE:002080) Problems Go Beyond Weak Profit

Nov 04
Sinoma Science & TechnologyLtd's (SZSE:002080) Problems Go Beyond Weak Profit

Even With A 44% Surge, Cautious Investors Are Not Rewarding Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Performance Completely

Oct 08
Even With A 44% Surge, Cautious Investors Are Not Rewarding Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Performance Completely

Should You Investigate Sinoma Science & Technology Co.,Ltd. (SZSE:002080) At CN¥9.99?

Sep 25
Should You Investigate Sinoma Science & Technology Co.,Ltd. (SZSE:002080) At CN¥9.99?

Estimating The Fair Value Of Sinoma Science & Technology Co.,Ltd. (SZSE:002080)

Sep 10
Estimating The Fair Value Of Sinoma Science & Technology Co.,Ltd. (SZSE:002080)

Bearish: Analysts Just Cut Their Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Revenue and EPS estimates

Aug 26
Bearish: Analysts Just Cut Their Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Revenue and EPS estimates

Sinoma Science & TechnologyLtd (SZSE:002080) Might Be Having Difficulty Using Its Capital Effectively

Aug 21
Sinoma Science & TechnologyLtd (SZSE:002080) Might Be Having Difficulty Using Its Capital Effectively

These 4 Measures Indicate That Sinoma Science & TechnologyLtd (SZSE:002080) Is Using Debt Extensively

Jul 25
These 4 Measures Indicate That Sinoma Science & TechnologyLtd (SZSE:002080) Is Using Debt Extensively

Why Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Could Be Worth Watching

Jun 10
Why Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Could Be Worth Watching

Sinoma Science & TechnologyLtd (SZSE:002080) Has Announced That Its Dividend Will Be Reduced To CN¥0.56

May 27
Sinoma Science & TechnologyLtd (SZSE:002080) Has Announced That Its Dividend Will Be Reduced To CN¥0.56

Capital Allocation Trends At Sinoma Science & TechnologyLtd (SZSE:002080) Aren't Ideal

May 13
Capital Allocation Trends At Sinoma Science & TechnologyLtd (SZSE:002080) Aren't Ideal

Are Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Investors Paying Above The Intrinsic Value?

Apr 14
Are Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Investors Paying Above The Intrinsic Value?

Earnings Troubles May Signal Larger Issues for Sinoma Science & TechnologyLtd (SZSE:002080) Shareholders

Mar 31
Earnings Troubles May Signal Larger Issues for Sinoma Science & TechnologyLtd (SZSE:002080) Shareholders

Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Price Is Right But Growth Is Lacking

Mar 14
Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Price Is Right But Growth Is Lacking

Should You Think About Buying Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Now?

Feb 28
Should You Think About Buying Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Now?

Earnings and Revenue Growth Forecasts

SZSE:002080 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202632,0981,9269255,6759
12/31/202528,6531,564-6174,32210
12/31/202423,9181,138-1,6194,6017
9/30/202424,3881,1261596,434N/A
6/30/202424,0501,298-3,1524,436N/A
3/31/202425,2762,027-3,8064,305N/A
12/31/202325,8892,224-2,9454,820N/A
9/30/202326,3172,836-5,1462,289N/A
6/30/202326,7573,079-3,6233,021N/A
3/31/202326,1963,253-2,2903,227N/A
1/1/202325,8143,574-1,6323,031N/A
9/30/202223,4623,1722053,415N/A
6/30/202222,3723,4136972,984N/A
3/31/202220,9343,5186032,352N/A
12/31/202120,2953,3731,8693,672N/A
9/30/202120,5223,1591,4823,255N/A
6/30/202120,6002,9771,6643,800N/A
3/31/202119,9992,3875162,986N/A
12/31/202018,8652,0405603,273N/A
9/30/202017,0381,8892343,295N/A
6/30/202015,1481,6341483,084N/A
3/31/202013,8211,4051,1793,557N/A
12/31/201913,5901,3807932,970N/A
9/30/201913,1481,1671572,021N/A
6/30/201912,7321,165-1531,621N/A
3/31/201911,985962-5741,378N/A
12/31/201811,411894-1471,564N/A
9/30/201810,807913-1,203630N/A
6/30/201810,504778N/A771N/A
3/31/201810,289778N/A654N/A
12/31/201710,237767N/A770N/A
9/30/20179,695699N/A1,622N/A
6/30/20179,386539N/A1,161N/A
3/31/20179,205499N/A1,118N/A
12/31/20168,700438N/A1,082N/A
9/30/20168,785436N/A858N/A
6/30/20168,813568N/A1,103N/A
3/31/20169,728678N/A861N/A
12/31/20159,176630N/A1,399N/A
9/30/20158,216613N/A654N/A
6/30/20156,989451N/A767N/A
3/31/20154,837194N/A944N/A
12/31/20144,424152N/A382N/A
9/30/20143,981108N/A601N/A
6/30/20143,68092N/A731N/A
3/31/20143,54596N/A88N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 002080's forecast earnings growth (25.8% per year) is above the savings rate (2.8%).

Earnings vs Market: 002080's earnings (25.8% per year) are forecast to grow faster than the CN market (25% per year).

High Growth Earnings: 002080's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 002080's revenue (13.4% per year) is forecast to grow slower than the CN market (13.5% per year).

High Growth Revenue: 002080's revenue (13.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 002080's Return on Equity is forecast to be low in 3 years time (7.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 14:50
End of Day Share Price 2025/01/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sinoma Science & Technology Co.,Ltd. is covered by 23 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Aaron HoCFRA Equity Research
Chao FanChangjiang Securities Co. LTD.
Ce ZhouChasing Securities